News Details

The global OEM manufacturing industry for health products is undergoing structural upgrading, and Chinese factories are accelerating their expansion into overseas customized markets.

The global dietary nutrition supplements and functional food market has maintained long-term growth. The health awareness of overseas consumers has continued to increase, driving the continuous expansion of the demand for customized OEM/ODM products in the field of big health. In the post-pandemic era, the purchasing logic of overseas brand manufacturers has significantly changed. They now prioritize selecting production enterprises that have compliance capabilities, formula development, new raw material application, and stable delivery capabilities. The domestic big health OEM export trade sector has ushered in structural opportunities, while also facing multiple challenges in terms of compliance, technology, and supply chain.

From the market trend, the mainstream overseas markets such as Europe, Asia-Pacific, and the Middle East show differentiated demands. The European and American markets have strict requirements for product raw material traceability, production norms, and label regulations. Consumers prefer natural, no-additives, and non-genetically modified dietary supplement products. Hard capsules, tablets, powders, and pills are in stable demand. The emerging markets in Southeast Asia and the Middle East have faster consumption growth, and customers place more emphasis on product cost performance and flexibility for small batch trial orders. The orders for solid beverages, tablet candies, and herbal health products have been increasing year by year. Different regional regulatory barriers have become the primary consideration factor in the cooperation between overseas brands and domestic OEM factories.

The development and application of new raw materials have become the core competitiveness of foreign trade OEM enterprises. In recent years, functional new raw materials have emerged continuously in the global market, such as postbiotics, red maple seed oil, N-acetyl neuraminic acid, and D-handedinositol, which have gradually been applied to various dietary products. Factories that can master the debugging of new raw material formulas, stability tests, and product inspection capabilities can help overseas brands create differentiated products and avoid homogeneous low-price competition. For foreign trade customers, whether the OEM factory can provide complete sets of materials such as CoA, TDS, and SGS testing directly determines whether the products can smoothly complete import customs clearance and local market launch.

Compliance systems and quality control capabilities are the entry bottom line for global health OEM. The regulatory systems for food and dietary supplements in various overseas countries are different, with strict regulations on label language, component limits, and claims. Excellent OEM enterprises need to establish a full-chain quality control system from raw material entry, production process monitoring to finished product inspection, and have standardized clean workshops, be familiar with the regulatory requirements of different target markets, assist customers in avoiding risks such as non-compliant labels and excessive components, and reduce losses from product detention and recall in overseas markets.

The OEM/ODM cooperation model is continuously evolving, and flexible production has become a necessity. In the past, overseas customers were accustomed to placing large orders, but now a large number of overseas start-up health brands prefer small batch prototyping and trial sales, and then expand production capacity after market verification. Domestic leading OEM factories are constantly upgrading flexible production lines, supporting formula customization, packaging customization, and foreign language label customization. Shandong Qingbaotang Biological Pharmaceutical Co., Ltd. can undertake customer-owned formula OEM, and can also output mature formulas for customers to license, covering small batch trial orders and large-scale production needs, and adapting to the phased market layout of overseas brands.

Industry observations indicate that in the future competition in the global health OEM sector, it is no longer just a competition of production capacity, but a competition of comprehensive strength in formula research and development, compliance services, supply chain stability, and cross-border delivery. Domestic factories such as Shandong Qingbaotang Biological Pharmaceutical, which have continuously deepened their OEM/ODM business, have improved export supporting services, strengthened new raw material research and quality control management, and opened customized OEM investment and recruitment to global brand owners and import traders. Relying on a complete production chain and a foreign trade service team, it helps overseas customers quickly implement health products, and jointly explores the global functional health consumption market.